| Bladder Bank (a Prospective Banking Study) (NCT06109857) | Mayo Clinic | 2022-07-06 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (NCT05059444) | Guardant Health, Inc. | 2021-09-07 |
| Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy (NCT04502095) | Roswell Park Cancer Institute | 2020-09-02 |
| Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers (NCT04459273) | Jonsson Comprehensive Cancer Center | 2020-08-27 |
| hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" (NCT03824691) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2019-09-25 |
| Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer (NCT05399004) | Mayo Clinic | 2019-09-03 |
| Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms (NCT03549650) | Sir Mortimer B. Davis - Jewish General Hospital | 2019-05-03 |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery (NCT03757949) | SWOG Cancer Research Network | 2019-03-05 |
| Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer (NCT02438852) | University of Southern California | 2019-02-25 |
| First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma (NCT03324282) | University Hospital, Bordeaux | 2018-02-23 |
| TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer (NCT03125226) | University of Washington | 2017-10-05 |
| The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery (NCT03064308) | University of Nottingham | 2017-06-26 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy (NCT02432963) | City of Hope Medical Center | 2016-06-14 |
| Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy (NCT02145390) | University of Miami | 2016-01-05 |
| PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit) (NCT02439060) | University of Southern California | 2015-11-25 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers (NCT02408406) | City of Hope Medical Center | 2015-07-07 |
| Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT02355886) | University of Washington | 2015-04-22 |
| T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies (NCT02457650) | Shenzhen Second People's Hospital | 2015-04-01 |
| Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection (NCT02202044) | University of Colorado, Denver | 2015-02-24 |
| Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery (NCT02169284) | National Cancer Institute (NCI) | 2014-10-01 |
| A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy (NCT01245660) | University Hospital, Bordeaux | 2011-01-01 |
| First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma (NCT01215136) | Matthew Galsky | 2010-12-01 |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) (NCT00753415) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Cone Beam CT Scanning in Lung and Bladder Cancer. (NCT00469066) | AHS Cancer Control Alberta | 2007-05-01 |